- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.90 Å
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 7 residues within 4Å:- Chain C: E.207, P.208, V.250, L.257, N.258, G.373, V.439
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.373
NAG-NAG-BMA.4: 4 residues within 4Å:- Chain E: N.258, N.371, V.439
- Ligands: NAG.32
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:V.439
NAG-NAG-BMA.6: 9 residues within 4Å:- Chain G: E.207, V.250, L.257, N.258, N.371, G.373, V.439, S.440
- Ligands: NAG.45
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:G.373
- 47 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.7: 4 residues within 4Å:- Chain C: N.135, S.185, Q.186
- Ligands: NAG.8
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain C: F.155, N.156
- Ligands: NAG.7
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain C: V.178, R.188, N.193
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain C: N.226, N.236
- Ligands: NAG-NAG-NAG.1
Ligand excluded by PLIPNAG.11: 2 residues within 4Å:- Chain C: N.285, E.286
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain C: N.297, I.318, G.434
Ligand excluded by PLIPNAG.13: 5 residues within 4Å:- Chain C: T.293, Y.325, N.327, S.406, T.408
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain C: S.358, T.366, T.367, N.380, S.382
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain C: N.435, T.437
Ligand excluded by PLIPNAG.16: 5 residues within 4Å:- Chain C: S.287, V.288, K.289, S.440, N.441
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain C: N.138, I.146, I.147, M.150, K.151
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain D: N.105
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain D: K.122, E.123, S.125, N.126
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain D: N.100, T.102, W.103, I.130
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain D: N.145
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain E: N.135, Q.186
- Ligands: NAG.24
Ligand excluded by PLIPNAG.23: 6 residues within 4Å:- Chain E: T.140, A.141, N.152, L.171, G.315, Q.316
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain E: T.133, N.156, Q.186
- Ligands: NAG.22
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain E: V.178, R.188, N.193
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain E: N.226
- Ligands: NAG-NAG-NAG.3
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain E: G.264, E.265, N.285, E.286
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain E: N.297, N.435
- Ligands: NAG.31
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain E: N.327, S.406, I.407, T.408
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain E: T.366, T.367, N.380, S.382
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain E: N.435, I.436, T.437
- Ligands: NAG.28
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain E: L.261, S.287, N.441
- Ligands: NAG-NAG-BMA.4
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain E: E.92, N.93
- Chain F: A.15, G.16, S.17
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain E: T.137, N.138, I.146
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain E: P.357, N.386
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain F: N.100, T.102
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain G: T.133, L.134, N.135, S.185, Q.186
Ligand excluded by PLIPNAG.38: 6 residues within 4Å:- Chain G: A.139, T.140, N.152, L.171, G.315, Q.316
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain G: F.155, N.156, R.165, E.166, K.167
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain G: N.226, T.228, N.237
- Ligands: NAG-NAG-NAG.5
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain G: N.285, E.286
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain G: N.297, N.435
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain G: R.322, Y.325, N.327, S.406, T.408
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain G: N.435, T.437
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain G: L.261, S.287, N.441
- Ligands: NAG-NAG-BMA.6
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain G: E.92, N.93
- Chain H: S.17
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain G: T.366, T.367, N.380
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain G: P.357, S.382, N.386
Ligand excluded by PLIPNAG.49: 5 residues within 4Å:- Chain G: E.330, S.331, N.334, S.387, W.389
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain G: N.138, I.146
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain H: N.100, T.102
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain H: N.105
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain H: K.122, E.123, S.125, N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RUu-V1V2V3-2 pAb heavy chain: A
RUu-V1V2V3-2 pAb light chain: B
BG505-CH505 Envelope glycoprotein gp120: CEG
BG505-CH505 Transmembrane protein gp41: DFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
CE
AG
ED
DF
BH
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.90 Å
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 47 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RUu-V1V2V3-2 pAb heavy chain: A
RUu-V1V2V3-2 pAb light chain: B
BG505-CH505 Envelope glycoprotein gp120: CEG
BG505-CH505 Transmembrane protein gp41: DFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
CE
AG
ED
DF
BH
F